Skip to main navigation
Close
Main navigation
Advocacy
Issue Overview
Sustainable Supply Chain
Biosimilars
IP & Patent Reform
Medicaid Generics Penalty
State Legislation
Trade
Events
Our Impact
About Us
Generic Quality
About the Association
Our Team
Our Members
Meet Our Board
Social Commitment
Generic Medicines
Biosimilars
Careers
Contact Us
Resources
Search Resources
2020 Access and Savings Report
Supply Chain Blueprint
Industry Response to COVID-19
Press Releases
Blog
State Lawmaker Toolkit
Amicus Briefs
Join
Take Action
Menu
In the News
- AAM CEO Dan Leonard shares the industry's 2021 outlook with Chain Drug Review.
Learn More
Close
Breadcrumb
Home
Resources
Resources
Share
Find up-to-date information on generics and biosimilars
Filter Resources
Issues
Biosimilars
Drug Approval Process (GDUFA)
Drug Prices
Drug Shortages
Generic Drug Labeling
Generic Supply Chain
IP Issues
Low Income Subsidies (LIS in Part D)
Medicaid
Medicare
NAFTA
Patent Reform
Pharmaceutical Waste Take Back
Preventing Drug Abuse
Quality
REMS/Sample Acquisition Remedies
State Initiatives
Tariffs
Trade
Transparency
User Fees
Resource Type
Blog
Amicus Brief
Press Release
Infographic
Video
Report
Fact Sheet
Presentation
Blog
Nov 25, 2020
| Erica Klinger
Health Care Savings, State by State
Press Release
Nov 20, 2020
| Rachel Schwartz
AAM Statement on Trump’s Drug Pricing Ruling – Rebates and Most Favored Nation Model
Press Release
Nov 11, 2020
| Rachel Schwartz
AAM Statement on 2020 Election
Blog
Nov 2, 2020
| Jewel Smith
Member Spotlight: Sandoz
Blog
Oct 29, 2020
| Erica Klinger
Top 10 Ways to Commemorate 10 Years of Biosimilars in the U.S.
Blog
Oct 23, 2020
| Bob Billings
Thank you, Mike Puskar
Blog
Oct 20, 2020
| Sara Skubikowski
Adding up the Generic Savings for Americans with Cancer and Other Conditions
Blog
Oct 15, 2020
| Erica Klinger
Jeni Got Her Life Back, Thanks to a Biosimilar
Video
Oct 8, 2020
| Erica Klinger
Jeni's Story — Biosimilars Savings
Press Release
Oct 7, 2020
| Rachel Schwartz
AAM Statement on the Introduction of the Protecting Access to Affordable Medicines Act of 2020
Report
Oct 6, 2020
| Erica Klinger
White Paper: Nitrosamines — An Industry Position Paper Based on Risk
Fact Sheet
Oct 5, 2020
| Ericka Nguyen
Generic Drugs and Biosimilars Secure Big Savings for U.S. Patients
Load More
Advocacy
Issue Overview
Sustainable Supply Chain
Biosimilars
IP & Patent Reform
Medicaid Generics Penalty
State Legislation
Trade
Events
GRx+Biosims 2020
Our Impact
About Us
Generic Quality
About the Association
Our Team
Our Members
Meet Our Board
Social Commitment
Generic Medicines
Biosimilars
Careers
Contact Us
Resources
Search Resources
2020 Access and Savings Report
Supply Chain Blueprint
Industry Response to COVID-19
Press Releases
Blog
State Lawmaker Toolkit
Amicus Briefs
Join
Take Action